CD28‐mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: Evidence for functionally distinct forms of CD28
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
JJ316 and JJ319 are rat CD28‐specific monoclonal antibodies (mAb) of the γ1χ isotype with identical co‐stimulatory potency. At a concentration 100–1000‐fold higher than that required for co‐stimulation, JJ316, but not JJ319 induces massive proliferation of all T cell subsets in vitro without T cell receptor (TCR) triggering. “Direct” stimulation by JJ316 is fully blocked by JJ319, indicating that it is not due to cross‐reactivity of JJ316 with the TCR complex or other activating receptors. JJ316 binds much more slowly to primary T cells than JJ319, whereas both antibodies bind with similar kinetics to CD28‐transfected L‐929 cells, suggesting that JJ316 binding to T cells requires redistribution or a conformational change of CD28. In vivo, JJ316 but not JJ319 induces rapid and transient proliferation of most CD4 T cells and, indirectly, of B cells. These data show that TCR engagement is not an absolute prerequisite either in vitro or in vivo for the induction of T cell proliferation through CD28 and suggest that mAb JJ316 is able to stimulate resting T cells directly by recruiting CD28 molecules from an inactive to an active form.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TGN1412 was called a 'superagonist' because it could activate T-cells without the need for prior engagement of the T-cell receptor complex (Tacke et al., 1997;Lühder et al., 2003).”
From Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4 + effector memory T‐cells (2010) · cites this paper as Tacke et al., 1997
In the citing paper
“Unexpectedly, we found that some rat CD28-specific mAbs activated T cells without the need to also engage the TCR [1].”
From The rise and fall of the CD 28 superagonist TGN 1412 and its return as TAB 08: a personal account (2016) · cites this paper as [1]
Citations
Cites
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
Bretscher, P., & Cohn, M. (1970) · Science · doi:10.1126/science.169.3950.1042 · Cited by 1,692
CTLA-4 is a second receptor for the B cell activation antigen B7.
Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.561 · Cited by 1,685
T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1
Dustin, M. L., & Springer, T. A. (1989) · Nature · doi:10.1038/341619a0 · Cited by 1,538
A new member of the immunoglobulin superfamily—CTLA-4
Brunet, J.-F., Denizot, F., Luciani, M.-F., Roux-Dosseto, M., Suzan, M., Mattei, M.-G., & Golstein, P. (1987) · Nature · doi:10.1038/328267a0 · Cited by 1,306
Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.721 · Cited by 1,127
Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain
Cao, X., Shores, E. W., Hu-Li, J., Anver, M. R., Kelsail, B. L., Russell, S. M., Drago, J., Noguchi, M., Grinberg, A., Bloom, E. T., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90047-0 · Cited by 1,038
Linsley, P. S., Greene, J. L., Brady, W., Bajorath, J., Ledbetter, J. A., & Peach, R. (1994) · Immunity · doi:10.1016/s1074-7613(94)80021-9 · Cited by 980
B70 antigen is a second ligand for CTLA-4 and CD28
Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J. H., Lanier, L. L., & Somoza, C. (1993) · Nature · doi:10.1038/366076a0 · Cited by 909
Cited by
Items 101–191 of 191
Urakami, H., Ostanin, D. V., Hünig, T., & Grisham, M. B. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.10.042 · Cited by 24
Self-citationGrosse‐Hovest, L., Wick, W., Minoia, R., Weller, M., Rammensee, H., Brem, G., & Jung, G. (2005) · International Journal of Cancer · doi:10.1002/ijc.21294 · Cited by 23
“This phenomenon was originally described by Tacke et al.(3) using particular superagonistic antibodies against rat CD28.”
BackgroundFarzaneh, L., Kasahara, N., & Farzaneh, F. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0189-8 · Cited by 23
Cirka, H., & Nguyen, T. (2025) · Advances in Wound Care · doi:10.1089/wound.2024.0082 · Cited by 23
Guelen, L., Fischmann, T. O., Wong, J., Mauze, S., Guadagnoli, M., Bąbała, N., Wagenaars, J., Juan, V., Rosen, D. B., Prosise, W., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005049 · Cited by 22
CD28 between tolerance and autoimmunity: the side effects of animal models
Porciello, N., Kunkl, M., & Tuosto, L. (2018) · F1000Research · doi:10.12688/f1000research.14046.1 · Cited by 20
Selective Costimulation Blockade With Antagonist Anti-CD28 Therapeutics in Transplantation
Vanhove, B., Poirier, N., Soulillou, J., & Blancho, G. (2019) · Transplantation · doi:10.1097/tp.0000000000002740 · Cited by 19
Copsel, S. N., Wolf, D., Komanduri, K. V., & Levy, R. B. (2019) · Haematologica · doi:10.3324/haematol.2018.198838 · Cited by 19
Langenhorst, D., Gogishvili, T., Ribechini, E., Kneitz, S., McPherson, K., Lutz, M. B., & Hünig, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050080 · Cited by 19
Self-citationKenter, M. J. H., & Cohen, A. F. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12605 · Cited by 17
Singh, M., Basu, S., Camell, C. D., Couturier, J. P., Nudelman, R. J., Medina, M. Á., Rodgers, J. R., & Lewis, D. E. (2008) · European Journal of Immunology · doi:10.1002/eji.200737929 · Cited by 17
Modulating T-cell costimulation as new immunosuppressive concept in organ transplantation
Pilat, N., Schwarz, C. C., & Wekerle, T. (2012) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328355fc94 · Cited by 16
Human-like Response of Pig T Cells to Superagonistic Anti-CD28 Monoclonal Antibodies
Uehlein, S., Ding, X., Flößer, J., Schmidt, S., Steitz, J., Bille, M., Schnitter, F., Baltes, S., Saalmüller, A., Gerner, W., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100174 · Cited by 15
Gogishvili, T., Elias, F., Emery, J. L., McPherson, K., Okkenhaug, K., Hünig, T., & Dennehy, K. M. (2008) · European Journal of Immunology · doi:10.1002/eji.200838223 · Cited by 15
Self-citationExperimental Autoimmune Neuritis
Gold, R., Stoll, G., Kieseier, B. C., Hartung, H., & Toyka, K. V. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-9491-7.50030-2 · Cited by 15
Kerstan, A., Armbruster, N. S., Leverkus, M., & Hünig, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7689 · Cited by 15
Self-citationMichaelis, K., Wallbrecht, K., Kerstan, A., Beyersdorf, N., Williams, C. A., Kerkau, T., Wang, X., Hünig, T., & Schön, M. P. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.01031.x · Cited by 14
Self-citationMelo, V. A., Nelemans, L. C., Vlaming, M. R., Lourens, H. J., Wiersma, V. R., Bilemjian, V., Huls, G. A., de Bruyn, M., & Bremer, E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1191866 · Cited by 13
T Cell Co-Stimulation: Inhibition of Immunosuppression?
Sundqvist, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00974 · Cited by 13
Sester, U., Wabnitz, G. H., Kirchgessner, H., & Samstag, Y. (2007) · European Journal of Immunology · doi:10.1002/eji.200737206 · Cited by 12
Pedros, C., Papapietro, O., Colacios, C., Casemayou, A., Bernard, I., Garcia, V., Lagrange, D., Mariamé, B., Andréoletti, O., Fournié, G. J., et al. (2013) · Genes and Immunity · doi:10.1038/gene.2013.21 · Cited by 12
Treatment and Prevention of Experimental Autoimmune Myocarditis with CD28 Superagonists
Wang, S., Liu, J., Wang, M., Zhang, J., & Wang, Z. (2009) · Cardiology · doi:10.1159/000256660 · Cited by 12
de Inés, C., Cochlovius, B., Schmidt, S., Kipriyanov, S. M., Rode, H.-J., & Little, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3948 · Cited by 12
Müller, D., & Kontermann, R. E. (2007) · Wiley eBooks · doi:10.1002/9783527619740.ch15 · Cited by 12
Spiesberger, K., Paulfranz, F., Egger, A., Reiser, J., Vogl, C., Rudolf-Scholik, J., Mayrhofer, C., Große‐Hovest, L., & Brem, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140471 · Cited by 11
CD4-Mediated Inhibiton of IL-2 Production in Activated T Cells
Bonnard, M., Haughn, L., & Julius, M. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1252 · Cited by 11
Elsayed, A., Pellegrino, C. E., Plüss, L., Peissert, F., Benz, R., Ulrich, F., Thorhallsdottir, G., Plaza, S. D., Villa, A., Mock, J., et al. (2023) · mAbs · doi:10.1080/19420862.2023.2220839 · Cited by 10
Müller, D., & Kontermann, R. E. (2014) · Wiley eBooks · doi:10.1002/9783527682423.ch11 · Cited by 10
Molecular Determinants of Inverse Agonist Activity of Biologicals Targeting CTLA-4
Teft, W. A., & Madrenas, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3631 · Cited by 10
Langenhorst, D., Tabares, P., Gulde, T., Becklund, B. R., Berr, S., Surh, C. D., Beyersdorf, N., & Hünig, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01985 · Cited by 9
Self-citationTakabatake, Y., Li, X., Mizui, M., Miyasato, K., Matsui, I., Kawada, N., Imai, E., Hünig, T., Takahara, S., Wada, T., et al. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00229 · Cited by 9
Self-citationReactivating exhausted tumor-infiltrating T cells by a bispecific DC-T cell engager in mice
Zhang, X., Gao, Y., Hu, W., Liang, Y., Yin, X., Shi, X., Li, H., Liao, H., Guo, J., Yu, X., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70876-4 · Cited by 8
Mechanism-Driven Design of Multispecific Antibodies for Targeted Disease Treatment
Fine, J., Meksiriporn, B., Tan, J., & Spangler, J. B. (2024) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-100522-102155 · Cited by 8
Mechanotransduction through T cell receptors: consensus, controversies and future outlooks
Travaglino, S., Jeon, Y., Kim, Y., Zhu, C., & Choi, H.-K. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01639-w · Cited by 7
Embracing the heterogeneity of natural viruses in mouse studies
Fiege, J. K., & Langlois, R. A. (2022) · Journal of General Virology · doi:10.1099/jgv.0.001758 · Cited by 7
A wild microbiome improves mouse modeling of the human immune response
Hamilton, S. E., & Griffith, T. S. (2019) · Lab Animal · doi:10.1038/s41684-019-0421-8 · Cited by 7
FK778: New Cellular and Molecular Mechanisms of Action
Schrepfer, S., Deuse, T., Koch‐Nolte, F., Detter, C., & Reichenspurner, H. C. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.01.058 · Cited by 6
Roelcke, V. (2022) · Science in Context · doi:10.1017/s0269889723000170 · Cited by 5
Innate responses to gut microbiota; critical assessment of the necessary experimental controls
McCoy, K. D., & Ohland, C. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.07.008 · Cited by 5
Immunostimulatory antibodies: Challenging the drug testing paradigm
Bhogal, N., & Combes, R. D. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.02.010 · Cited by 4
Hoffmann, J., Peters, K., Pawlowski, N. N., Grollich, K., Henschke, S., Herrmann, B., Zeitz, M., & Westermann, J. (2009) · Immunological Investigations · doi:10.1080/08820130902888342 · Cited by 3
Azuma, H., Isaka, Y., Nomi, H., Inamoto, T., Li, X., Hőunig, T., Takabatake, Y., Ichimaru, N., Ibuki, N., Matsumoto, K., et al. (2010) · Transplantation · doi:10.1097/tp.0b013e3182007b59 · Cited by 3
Realizing the potential of agonistic antibody immunotherapy
Cragg, M. S., Yu, X., Paluch, C., & Davis, S. J. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-026-01442-2 · Cited by 2
Cloning, purification and bioactivity assay of human CD28 single-chain antibody in Escherichia coli
Zheng, F., Qiu, Y., Chen, Y., Chen, P., Zhu, Y., Xie, W., Zhu, H.-T., & Zhu, J. (2009) · Cytotechnology · doi:10.1007/s10616-009-9218-8 · Cited by 2
Early De-risking Strategy for Novel Biotherapeutics
Narayanan, P. K., Ponce, R. A., & Hinkle, B. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394810-6.00003-4 · Cited by 2
Laskowski, I. A., Pratschke, J., Wilhelm, M. J., Paz, D., Ames, J., Dong, V. M., Beato, F., Sayegh, M. H., Hancock, W. W., & Tilney, N. L. (2001) · Transplantation Proceedings · doi:10.1016/s0041-1345(00)02145-x · Cited by 2
Principles of Protein Recognition by Small T-Cell Adhesion Proteins and Costimulatory Receptors
Ikemizu, S., & Davis, S. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-803369-2.00002-4 · Cited by 1
Early de-risking strategy for biotherapeutics
Narayanan, P. K., Dahlman, A., & Peng, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13344-2.00002-x · Cited by 1
IgE Inhibitors in Phase 1 and 2 Clinical Studies for Immunological Disorders
Brennan, F. R. (2014) · Wiley eBooks · doi:10.1002/9783527682423.ch36 · Cited by 1
Human mucosal CD4+ T cells but not blood CD4+ T cells respond vigorously towards CD28 engagement
Schröder–Braunstein, J., Pavlov, V., Giese, T., Heidtmann, A., Wentrup, S., Lasitschka, F., Winter, J., Ulrich, A. B., Engelke, A., Saeedi, M. A., et al. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04539.x · Cited by 1
Wagner, J., Leicht, S., Hofmann, M., Seifert, F., Gahn, S., Germer, C., Beyersdorf, N., Otto, C., & Klein, I. (2021) · Immunobiology · doi:10.1016/j.imbio.2021.152144 · Cited by 1
T Cell Inhibitors in Phase 1 and 2 Clinical Studies for Immunological Disorders
Brennan, F. R. (2014) · Wiley eBooks · doi:10.1002/9783527682423.ch32 · Cited by 1
Von der Infektion zur Autoimmunität
Siffrin, V. (2005) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/15250 · Cited by 1
Vav1 contrôle le développement des lymphocytes T régulateurs et des maladies d'origine immune
Casemayou, A. (2010) · Thèses en ligne de l'Université Toulouse III (Université Toulouse III)
Papapietro, O. (2009) · Thèses en ligne de l'Université Toulouse III (Université Toulouse III)
Funktionelle Charakterisierung der Signaltransduktionskaskade des LFA-1-Integrins
Sirim, P. (2001) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.371
CD5-Mediated inhibition of tlymphocyte signaling.
Bamberger, M. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/tns6-t086
TGN1412: Superagonist Dr. Jekyll and
Criado, G. (2006)
Improving stability of human regulatory T cells for clinical purposes
He, X. (2016) · Radboud Repository (Radboud University)
T cell costimulatory pathways – the role of vitamin D3
Gardner, D. H. (2016) · University of Birmingham Institutional Research Archive (University of Birmingham)
Brück, W., Stadelmann, C., Hohnstein, T., Volkmer, R., Nogai, A., Siffrin, V., Bonhagen, K., & Caspar, F. (2013)
Safety Considerations for Biologics
Dempster, M., Weir, L. R., & Fagg, R. (2017) · Methods and principles in medicinal chemistry · doi:10.1002/9783527699124.ch11
A Mechanism of ATF5 Anti-Apoptotic Action that Promotes Leukemia Cells SurvivalPreprint
Persengiev, S. P. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/193292
Monoclonal Antibodies for Immune System-Mediated Diseases
Brennan, F. R., Smith, E., & Dudal, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-10811-3_21
Mechanismen der TZR-abhängigen und -unabhängigen Aktivierung primärer T-Zellen der Ratte durch CD 28
Bischof, A. (2000) · Online Publication Service of Würzburg University (Würzburg University)
Kellner, C. (2008) · OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg)
Modulation der Immunglobulinproduktion bei Ratten mit CD28-spezifischen monoklonalen Antikörpern
Thumbs, A. (2000) · Online Publication Service of Würzburg University (Würzburg University)
Haack, S. (2021) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-23775
Haspot, F. (2004) · OpenGrey (Institut de l'Information Scientifique et Technique)
McGeachy, M. J. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732850338.793546604
Analysis of Sterols in Human T Helper Cells
Yutuc, E. (2017) · Cronfa (Swansea University) · doi:10.23889/suthesis.60641
Sender, L. Y. (2010) · Institutional Repository of Leibniz Universität Hannover (Leibniz Universität Hannover) · doi:10.15488/7520
Badr, M. (2023) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-28954
Brooks, J. (2018) · Institutional Repository of Leibniz Universität Hannover (Leibniz Universität Hannover) · doi:10.15488/9114
Blank, G. (2009) · Online Publication Service of Würzburg University (Würzburg University)
Entwicklung von dual anvisierenden Antikörper-Derivaten zur Therapie von Neoplasien der B-Zellreihe
Schubert, I. A. (2010) · OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg)
The role of CD28 costimulation for CD8 T-cell memory responses
Fröhlich, M. G. (2017) · Online Publication Service of Würzburg University (Würzburg University)
Tischner, D. (2007) · Online Publication Service of Würzburg University (Würzburg University)
Role of FcγRs in anti-OX40 based immunotherapies
Costoya, C. (2023) · UCL Discovery (University College London)
Leicht, S. (2025) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-42136
PD-1 et BTLA au coeur des lymphocytes B : du physiologique aux lymphomes
Thibult, M. (2011) · theses.fr (ABES) · doi:10.70675/9fced0cfz093cz4a5az9efcz599aecffc537
Mailer, R. K., Mengel, M., Kröger, B., Malle, M., Frye, M., Renné, T., Yorgan, T. A., & Diercks, B. (2026) · Research Square · doi:10.21203/rs.3.rs-11036225/v1
A defined multi-kingdom microbial consortium naturalizes the immune system of laboratory micePreprint
Yang, Y., Liu, S., Zhou, C., Bayard, N., Krishnamurthy, S. R., Gerrick, E. R., Howitt, M. R., Shaw, S., Striepen, B., Ruella, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.09.757975
van Hees, E. P., Starink, L. I. W., Poortvliet, T., Hagedoorn, R. S., Remst, D. F. G., Arens, R., & Heemskerk, M. H. M. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag313
Melo, V., Nelemans, L. C., Vlaming, M., Lourens, H. J., Wiersma, V. R., Bilemjian, V., Huls, G., de Bruyn, M., & Bremer, E. (2023) · doi:10.3389/fimmu.2023.1191866.s001
Rodriguez-Palmero, M. (1999) · doi:10.1002/(sici)1521-4141(199912)29:12<3914::aid-immu3914>3.0.co;2-#
Self-citationBischof, A. (2000) · doi:10.1002/1521-4141(200003)30:3
Self-citation
Metadata
- Authors
- Tacke, M., Hanke, G., Hanke, T., & Hünig, T.
- Affiliations
- University of Würzburg (DE)
- Corresponding author
- Hünig, Thomas
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1997-01
- Volume
- 27
- Issue
- 1
- Pages
- 239-247
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1986805605
- Cited by
- 163
- References
- 39
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 4 · 2020: 2 · 2019: 9 · 2018: 6 · 2017: 4 · 2016: 2 · 2015: 8 · 2014: 5 · 2013: 8 · 2012: 6
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- CD28, T cell costimulation, T cell proliferation, resting T cells, T cell receptor, monoclonal antibodies, CD4+ T cells, B cell activation, T cell activation
- MeSH terms
- Animals, Antibodies, Monoclonal, Cell Division, Female, Kinetics, Lymph Nodes, Lymphocyte Activation, Male, Membrane Glycoproteins, Rats, Inbred Lew, Receptors, Antigen, T-Cell, Spleen, T-Lymphocytes, Signal Transduction, Antigens, CD, Lymphocyte Subsets, CD28 Antigens, B7-1 Antigen, Rats, B7-2 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.